Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Additional excipient justification [Dissolution / BCS / IVIVC]

posted by nobody – 2014-11-30 21:44 (4220 d 13:58 ago) – Posting: # 13958
Views: 8,014

afaik only WHO considers (some limited) class II APIs egligilbe for biowaivers. Look up literature for ibuprofen to have details on limitations for this approach, has been discussed here in the past iirc...

Regards

nobody

—
Kindest regards, nobody

Complete thread:

Additional excipient justification srinivasuk 2014-11-30 08:53
- Biowaiver for BCS Class II? Helmut 2014-11-30 14:24
- Additional excipient justificationnobody 2014-11-30 20:44
  - Additional excipient justification Dr_Dan 2014-12-02 09:34
    - Additional excipient justification nobody 2014-12-02 10:38

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
149 visitors (0 registered, 149 guests [including 15 identified bots]).
Forum time: 12:43 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic. Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz